Correlation Between Lockheed Martin and SAB Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lockheed Martin and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lockheed Martin and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lockheed Martin and SAB Biotherapeutics, you can compare the effects of market volatilities on Lockheed Martin and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lockheed Martin with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lockheed Martin and SAB Biotherapeutics.

Diversification Opportunities for Lockheed Martin and SAB Biotherapeutics

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Lockheed and SAB is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Lockheed Martin and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Lockheed Martin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lockheed Martin are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Lockheed Martin i.e., Lockheed Martin and SAB Biotherapeutics go up and down completely randomly.

Pair Corralation between Lockheed Martin and SAB Biotherapeutics

Considering the 90-day investment horizon Lockheed Martin is expected to generate 0.14 times more return on investment than SAB Biotherapeutics. However, Lockheed Martin is 6.92 times less risky than SAB Biotherapeutics. It trades about 0.03 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.0 per unit of risk. If you would invest  46,845  in Lockheed Martin on August 24, 2024 and sell it today you would earn a total of  7,356  from holding Lockheed Martin or generate 15.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lockheed Martin  vs.  SAB Biotherapeutics

 Performance 
       Timeline  
Lockheed Martin 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lockheed Martin has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Lockheed Martin is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
SAB Biotherapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Lockheed Martin and SAB Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lockheed Martin and SAB Biotherapeutics

The main advantage of trading using opposite Lockheed Martin and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lockheed Martin position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.
The idea behind Lockheed Martin and SAB Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals